125 related articles for article (PubMed ID: 38796163)
1. Adverse Drug Event-Related Hospital Admissions among Australian Aged Care Residents: A Cross-Sectional Study.
Ali S; Peterson GM; Curtain CM; Wilson A; Salahudeen MS
J Am Med Dir Assoc; 2024 Jul; 25(7):105041. PubMed ID: 38796163
[TBL] [Abstract][Full Text] [Related]
2. Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals.
Parameswaran Nair N; Chalmers L; Bereznicki BJ; Curtain C; Peterson GM; Connolly M; Bereznicki LR
Drug Saf; 2017 Jul; 40(7):597-606. PubMed ID: 28382494
[TBL] [Abstract][Full Text] [Related]
3. Hospital admissions caused by adverse drug events: an Australian prospective study.
Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hospital admissions associated with adverse drug events.
Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
[TBL] [Abstract][Full Text] [Related]
5. Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic.
Maříková M; Očovská Z; Nerad V; Kuběna AA; Blaha V; Vlček J
Int J Clin Pharm; 2021 Oct; 43(5):1218-1226. PubMed ID: 33763812
[TBL] [Abstract][Full Text] [Related]
6. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study of the prevalence and characteristics of adverse drug events in adults who present to an Australian emergency department.
Brown NJ; Doran E; Greenslade JH; Lukin B; Cottrell N; Jaramillo F; Coombes I; Donovan P; Cullen L
Emerg Med Australas; 2022 Aug; 34(4):547-554. PubMed ID: 34973155
[TBL] [Abstract][Full Text] [Related]
8. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).
Klopotowska JE; Wierenga PC; de Rooij SE; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; Smorenburg SM;
BMC Health Serv Res; 2011 May; 11():124. PubMed ID: 21612624
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre, prospective study.
Fahrni ML; Azmy MT; Usir E; Aziz NA; Hassan Y
PLoS One; 2019; 14(7):e0219898. PubMed ID: 31348784
[TBL] [Abstract][Full Text] [Related]
10. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug events as a cause of hospital admission in the elderly.
Chan M; Nicklason F; Vial JH
Intern Med J; 2001; 31(4):199-205. PubMed ID: 11456032
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score).
Parameswaran Nair N; Chalmers L; Connolly M; Bereznicki BJ; Peterson GM; Curtain C; Castelino RL; Bereznicki LR
PLoS One; 2016; 11(10):e0165757. PubMed ID: 27798708
[TBL] [Abstract][Full Text] [Related]
13. Adverse Drug Event Rate in Israeli Hospitals: Validation of an International Trigger Tool and an International Comparison Study.
Zimlichman E; Gueta I; Daliyot D; Ziv A; Oberman B; Hochman O; Tamir O; Tal O; Loebstein R
Isr Med Assoc J; 2018 Nov; 20(11):665-669. PubMed ID: 30430793
[TBL] [Abstract][Full Text] [Related]
14. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, Nature, Severity and Preventability of Adverse Drug Events in Mental Health Settings: Findings from the MedicAtion relateD harm in mEntal health hospitals (MADE) Study.
Alshehri GH; Ashcroft DM; Nguyen J; Hann M; Jones R; Seaton K; Newton G; Keers RN
Drug Saf; 2021 Aug; 44(8):877-888. PubMed ID: 34224091
[TBL] [Abstract][Full Text] [Related]
16. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
Kunac DL; Kennedy J; Austin N; Reith D
Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
[TBL] [Abstract][Full Text] [Related]
17. Repeat Adverse Drug Reaction-Related Hospital Admissions in Elderly Australians: A Retrospective Study at the Royal Hobart Hospital.
Parameswaran Nair N; Chalmers L; Bereznicki BJ; Curtain CM; Bereznicki LR
Drugs Aging; 2017 Oct; 34(10):777-783. PubMed ID: 28952130
[TBL] [Abstract][Full Text] [Related]
18. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
[TBL] [Abstract][Full Text] [Related]
19. Recognition of adverse drug events in older hospitalized medical patients.
Klopotowska JE; Wierenga PC; Smorenburg SM; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; de Rooij SE;
Eur J Clin Pharmacol; 2013 Jan; 69(1):75-85. PubMed ID: 22673927
[TBL] [Abstract][Full Text] [Related]
20. Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity.
Otero MJ; Toscano Guzmán MD; Galván-Banqueri M; Martinez-Sotelo J; Santos-Rubio MD
Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e41-e46. PubMed ID: 32385069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
